{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:21:04Z","timestamp":1793532064629,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010805","name":"Fundaci\u00f3n Tatiana P\u00e9rez de Guzm\u00e1n el Bueno","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF16-75500-R"],"award-info":[{"award-number":["SAF16-75500-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004381","name":"Western University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7-HEALTH-2009-2.2.1-2-241909"],"award-info":[{"award-number":["FP7-HEALTH-2009-2.2.1-2-241909"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["HEALTH-2013-2.2.1-2-603196"],"award-info":[{"award-number":["HEALTH-2013-2.2.1-2-603196"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115916"],"award-info":[{"award-number":["115916"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["BRADE-CM S2013\/ICE-2958"],"award-info":[{"award-number":["BRADE-CM S2013\/ICE-2958"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["B2017\/BMD-3740 AGES-CM-2"],"award-info":[{"award-number":["B2017\/BMD-3740 AGES-CM-2"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["MV15\/00002"],"award-info":[{"award-number":["MV15\/00002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CPII14\/00005"],"award-info":[{"award-number":["CPII14\/00005"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01766"],"award-info":[{"award-number":["PI17\/01766"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/00860"],"award-info":[{"award-number":["PI14\/00860"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.euroneuro.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T04:23:50Z","timestamp":1561004630000},"page":"880-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Risperidone administered during adolescence induced metabolic, anatomical and inflammatory\/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model"],"prefix":"10.1016","volume":"29","author":[{"given":"Marta","family":"Casquero-Veiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1527-8895","authenticated-orcid":false,"given":"Karina S.","family":"MacDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"P\u00e9rez-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Torres-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fraguas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Berrocoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Desco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Soto-Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2019.05.002_bib0001","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cmpb.2011.06.008","article-title":"Software architecture for multi-bed FDK-based reconstruction in X-ray CT scanners","volume":"107","author":"Abella","year":"2012","journal-title":"Comput. Meth. Prog. Bio."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0002","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/cap.2015.0005","article-title":"Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial","volume":"25","author":"Aman","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0893-133X(02)00287-7","article-title":"Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs","volume":"27","author":"Andersson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0004","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1152\/jn.00387.2015","article-title":"Brain stem as a target site for the metabolic side effects of olanzapine","volume":"115","author":"Anwar","year":"2016","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0005","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0306-4522(03)00564-5","article-title":"Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist","volume":"121","author":"Barrientos","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0006","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.neuroimage.2012.04.010","article-title":"In vivo voxel based morphometry: detection of increased hippocampal volume and decreased glutamate levels in exercising mice","volume":"61","author":"Biedermann","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0007","first-page":"125","article-title":"Associations between maternal infection during pregnancy, childhood infections, and the risk of subsequent psychotic disorder\u2013a Swedish cohort study of nearly 2 million individuals","volume":"42","author":"Blomstrom","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1192\/bjpo.bp.115.002444","article-title":"The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study","volume":"2","author":"Bodnar","year":"2016","journal-title":"BJPsych Open"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0009","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.psyneuen.2012.12.025","article-title":"A systematic review of the activity of the hypothalamic-pituitary-adrenal axis in first episode psychosis","volume":"38","author":"Borges","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0010","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/s41386-018-0048-2","article-title":"Medial septum differentially regulates dopamine neuron activity in the rat ventral tegmental area and substantia nigra via distinct pathways","volume":"43","author":"Bortz","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0011","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tics.2013.03.003","article-title":"Cerebellar networks with the cerebral cortex and basal ganglia","volume":"17","author":"Bostan","year":"2013","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0012","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00406-015-0633-x","article-title":"FDG-PET scans in patients with Kraepelinian and non-Kraepelinian schizophrenia","volume":"266","author":"Bralet","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/oxfordjournals.schbul.a033331","article-title":"Positron emission tomography studies of abnormal glucose metabolism in schizophrenia","volume":"24","author":"Buchsbaum","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0920-9964(01)00361-9","article-title":"Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder","volume":"54","author":"Buchsbaum","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0015","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2016.15070890","article-title":"An individualized risk calculator for research in prodromal psychosis","volume":"173","author":"Cannon","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0016","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/schbul\/sbv095","article-title":"Diagnostic Concepts in the Context of Clinical High Risk\/Attenuated Psychosis Syndrome","volume":"41","author":"Carpenter","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8560232","article-title":"Understanding Deep brain stimulation: in vivo metabolic consequences of the electrode insertional effect","volume":"2018","author":"Casquero-Veiga","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204740","article-title":"Stimulating the nucleus accumbens in obesity: a positron emission tomography study after deep brain stimulation in a rodent model","volume":"13","author":"Casquero-Veiga","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0019","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(89)90040-1","article-title":"Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia","volume":"28","author":"Cleghorn","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.schres.2017.02.014","article-title":"Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis","volume":"189","author":"Chung","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0021","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nicl.2016.08.013","article-title":"Brain development in adolescents at ultra-high risk for psychosis: longitudinal changes related to resilience","volume":"12","author":"de Wit","year":"2016","journal-title":"NeuroImage. Clin."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0022","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2174\/156802612805289935","article-title":"Neurochemistry of schizophrenia: the contribution of neuroimaging postmortem pathology and neurochemistry in schizophrenia","volume":"12","author":"Dean","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2010.12.018","article-title":"Low doses of risperidone and morphine interact to produce more analgesia and greater extrapyramidal effects in rats","volume":"490","author":"DiPirro","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1139\/jpn.090049","article-title":"Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia","volume":"35","author":"Ebdrup","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1461145710000817","article-title":"Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms","volume":"14","author":"Ebdrup","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0026","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/nn.3844","article-title":"Pain and the PAG: learning from painful mistakes","volume":"17","author":"Eippert","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0027","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.biopsych.2005.02.028","article-title":"Serotonin transporter availability in patients with schizophrenia: a positron emission tomography imaging study with [11C]DASB","volume":"57","author":"Frankle","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pscychresns.2006.04.002","article-title":"Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia","volume":"154","author":"Fujimoto","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0029","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1038\/tp.2013.5","article-title":"Neonatal levels of acute phase proteins and later risk of non-affective psychosis","volume":"3","author":"Gardner","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyx067","article-title":"Differential patterns of subcortical activity evoked by glial GLT-1 blockade in prelimbic and infralimbic cortex: relationship to antidepressant-like effects in rats","author":"Gasull-Cam\u00f3s","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0031","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbi.2012.11.010","article-title":"Poly I:c-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression","volume":"28","author":"Gibney","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0032","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.euroneuro.2012.10.018","article-title":"The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?","volume":"23","author":"Godsil","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0033","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0074-7742(06)78012-6","article-title":"Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine","volume":"78","author":"Guillin","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0034","doi-asserted-by":"crossref","first-page":"10122","DOI":"10.3390\/ijms140510122","article-title":"TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders","volume":"14","author":"Gupta","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.schres.2015.05.010","article-title":"Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course","volume":"166","author":"Hadar","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0036","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/schbul\/sbs118","article-title":"Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects","volume":"39","author":"Haijma","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0037","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1176\/appi.ajp.161.2.305","article-title":"Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia","volume":"161","author":"Hazlett","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0038","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2016.10.020","article-title":"Altered interregional correlations between serotonin transporter availability and cerebral glucose metabolism in schizophrenia: a high-resolution PET study using [11C]DASB and [18F]FDG","volume":"182","author":"Kim","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0039","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pscychresns.2014.10.022","article-title":"Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET","volume":"231","author":"Kim","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000205518","article-title":"Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment","volume":"59","author":"Lee","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0041","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbr.2004.04.010","article-title":"The medial septum mediates impairment of prepulse inhibition of acoustic startle induced by a hippocampal seizure or phencyclidine","volume":"155","author":"Ma","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0042","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s13311-016-0438-2","article-title":"The atypical antipsychotic paliperidone regulates endogenous antioxidant\/anti-inflammatory pathways in rat models of acute and chronic restraint stress","volume":"13","author":"MacDowell","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0043","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S1461145711001775","article-title":"Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation","volume":"16","author":"MacDowell","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0044","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2016.12.025","article-title":"Paliperidone reverts Toll-like receptor 3 signaling pathway activation and cognitive deficits in a maternal immune activation mouse model of schizophrenia","volume":"116","author":"MacDowell","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pnpbp.2017.08.005","article-title":"Differential regulation of the TLR4 signalling pathway in post-mortem prefrontal cortex and cerebellum in chronic schizophrenia: relationship with SP transcription factors","volume":"79","author":"MacDowell","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0046","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/15622975.2016.1151075","article-title":"Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex","volume":"18","author":"MacDowell","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0047","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.11.029","article-title":"Modulation of the antioxidant nuclear factor (erythroid 2-derived)-like 2 pathway by antidepressants in rats","volume":"103","author":"Martin-Hernandez","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0048","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.jcp.0000155818.29091.53","article-title":"Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone","volume":"25","author":"Massana","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0049","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4088\/JCP.12m07785","article-title":"Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome","volume":"74","author":"McGorry","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0050","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-009-1482-y","article-title":"Contribution of dopamine receptors to periaqueductal gray-mediated antinociception","volume":"204","author":"Meyer","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0051","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol. Therap."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0052","first-page":"485","article-title":"Altering the course of schizophrenia: progress and perspectives","volume":"15","author":"Millan","year":"2016","journal-title":"Nat. Rev."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0053","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.pnpbp.2007.12.028","article-title":"Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients","volume":"32","author":"Molina","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0054","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S204579601400033X","article-title":"From stress to psychosis: whom, how, when and why?","volume":"23","author":"Mondelli","year":"2014","journal-title":"Epidemiol. Psychiatric Sci."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fpsyt.2013.00045","article-title":"BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory","volume":"4","author":"Nieto","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0056","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.psyneuen.2013.06.030","article-title":"Pituitary gland volume in patients with schizophrenia, subjects at ultra high-risk of developing psychosis and healthy controls: a systematic review and meta-analysis","volume":"38","author":"Nordholm","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0057","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2013.05.029","article-title":"The role of serotonin in cerebellar development","volume":"248","author":"Oostland","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0058","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0269881107084020","article-title":"Pituitary volume in psychosis: the first review of the evidence","volume":"22","author":"Pariante","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0059","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2008"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0060","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/schbul\/sbq040","article-title":"Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia","volume":"37","author":"Piontkewitz","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0061","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0062","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pscychresns.2014.11.004","article-title":"The relationship between stress, HPA axis functioning and brain structure in first episode psychosis over the first 12 weeks of treatment","volume":"231","author":"Reniers","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0063","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","article-title":"Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine","volume":"151","author":"Ribeiro","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0064","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/ng.2742","article-title":"Genome-wide association analysis identifies 13 new risk loci for schizophrenia","volume":"45","author":"Ripke","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0065","doi-asserted-by":"crossref","first-page":"e1093","DOI":"10.1038\/tp.2017.47","article-title":"Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis","volume":"7","author":"Sanders","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0066","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0067","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/YIC.0000000000000131","article-title":"Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?","volume":"31","author":"Schoretsanitis","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0068","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/wps.20454","article-title":"Moving interventions from after to before diagnosis","volume":"16","author":"Sommer","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0069","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/npjschz.2016.3","article-title":"Early interventions in risk groups for schizophrenia: what are we waiting for?","volume":"2","author":"Sommer","year":"2016","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0070","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.neuroimage.2011.08.065","article-title":"Functional topography of the cerebellum for motor and cognitive tasks: an fMRI study","volume":"59","author":"Stoodley","year":"2012","journal-title":"NeuroImage"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0071","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"33","author":"Sugino","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0072","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pnpbp.2010.10.023","article-title":"Longitudinal volume changes of the pituitary gland in patients with schizotypal disorder and first-episode schizophrenia","volume":"35","author":"Takahashi","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0073","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archpsyc.1992.01820070016003","article-title":"Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome","volume":"49","author":"Tamminga","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0074","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0006-8993(00)03192-9","article-title":"Electrolytic lesions of the medial septum enhance latent inhibition in a conditioned taste aversion paradigm","volume":"890","author":"Turgeon","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0075","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","article-title":"N4ITK: improved N3 bias correction","volume":"29","author":"Tustison","year":"2010","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0076","first-page":"26","article-title":"An in vivo MRI template set for morphometry, tissue segmentation, and fMRI localization in rats","volume":"5","author":"Valdes-Hernandez","year":"2011","journal-title":"Front Neuroinf."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0077","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mp.2015.118","article-title":"Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium","volume":"21","author":"van Erp","year":"2016","journal-title":"Mole. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0078","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbu069","article-title":"Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations","volume":"40","author":"van Os","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0079","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euroneuro.2009.04.008","article-title":"Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns","volume":"19","author":"Vitiello","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0080","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/ajp.144.2.151","article-title":"Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia","volume":"144","author":"Volkow","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2019.05.002_bib0081","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/wps.20424","article-title":"Treatment of people at ultra-high risk for psychosis","volume":"16","author":"Yung","year":"2017","journal-title":"World Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19302500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X19302500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:29:04Z","timestamp":1778549344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X19302500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0924977X19302500"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.05.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risperidone administered during adolescence induced metabolic, anatomical and inflammatory\/oxidative changes in adult brain: A PET and MRI study in the maternal immune stimulation animal model","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}